tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Anupam Rama, 295 are a BUY (75.26%), 67 are a HOLD (17.09%), 30 are a SELL (7.65%).
Analyst Anupam Rama, currently employed at JPMORGAN, carries an average stock price target met ratio of 42.18% that have a potential upside of 35.12% achieved within 211 days.
Anupam Rama’s has documented 763 price targets and ratings displayed on 58 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BBIO, BridgeBio Pharma at 03-Sep-2025.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 1/22/2024. The price target of $25 was fulfilled within 3 days with a profit of $8.7 (53.37%) receiving and performance score of 177.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$51
$14.22 (38.66%)
$71
1 months 28 days ago
(22-Jul-2025)
6/9 (66.67%)
$11.34 (28.59%)
477
Buy
$57
$20.22 (54.98%)
$55
9 months 9 days ago
(10-Dec-2024)
5/6 (83.33%)
$10.98 (23.86%)
84
Buy
$51
$14.22 (38.66%)
11 months 9 days ago
(10-Oct-2024)
1/1 (100%)
$9.18 (21.95%)
27
Hold
$56
$19.22 (52.26%)
$61
11 months 23 days ago
(27-Sep-2024)
10/13 (76.92%)
$10.39 (22.78%)
223
Hold
$46
$9.22 (25.07%)
$30
1 years 3 months 6 days ago
(13-Jun-2024)
4/4 (100%)
$-0.77 (-1.65%)
169
Which stock is Anupam Rama is most bullish on?
Which stock is Anupam Rama is most reserved on?
What Year was the first public recommendation made by Anupam Rama?
